These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9614552)
21. Tumour necrosis factor alpha (TNF-alpha) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA. Ohshima S; Mima T; Sasai M; Nishioka K; Shimizu M; Murata N; Yoshikawa H; Nakanishi K; Suemura M; McCloskey RV; Kishimoto T; Saeki Y Cytokine; 2000 Mar; 12(3):281-8. PubMed ID: 10704256 [TBL] [Abstract][Full Text] [Related]
22. Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice. Jorgensen C; Demoly P; Noel D; Mathieu M; Piechaczyc M; Gougat C; Bousquet J; Sany J J Rheumatol; 1997 Nov; 24(11):2076-9. PubMed ID: 9375863 [TBL] [Abstract][Full Text] [Related]
23. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644 [TBL] [Abstract][Full Text] [Related]
24. Defective Fas ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent to Mycoplasma pulmonis infection. Hsu HC; Zhang HG; Song GG; Xie J; Liu D; Yang PA; Fleck M; Wintersberger W; Zhou T; Edwards CK; Mountz JD Arthritis Rheum; 2001 Sep; 44(9):2146-59. PubMed ID: 11592380 [TBL] [Abstract][Full Text] [Related]
25. Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Perlman H; Pagliari LJ; Liu H; Koch AE; Haines GK; Pope RM Arthritis Rheum; 2001 Jan; 44(1):21-30. PubMed ID: 11212162 [TBL] [Abstract][Full Text] [Related]
26. Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium. Yao Q; Wang S; Gambotto A; Glorioso JC; Evans CH; Robbins PD; Ghivizzani SC; Oligino TJ Gene Ther; 2003 Jun; 10(12):1055-60. PubMed ID: 12776164 [TBL] [Abstract][Full Text] [Related]
27. Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells. Hedlund TE; Meech SJ; Srikanth S; Kraft AS; Miller GJ; Schaack JB; Duke RC Cell Death Differ; 1999 Feb; 6(2):175-82. PubMed ID: 10200564 [TBL] [Abstract][Full Text] [Related]
28. The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium. Silverman MD; Haas CS; Rad AM; Arbab AS; Koch AE Arthritis Rheum; 2007 Jun; 56(6):1817-26. PubMed ID: 17530710 [TBL] [Abstract][Full Text] [Related]
29. Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis. Palao G; Santiago B; Galindo M; PayĆ” M; Ramirez JC; Pablos JL Arthritis Rheum; 2004 Sep; 50(9):2803-10. PubMed ID: 15457448 [TBL] [Abstract][Full Text] [Related]
30. Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo. Nakanishi H; Mazda O; Satoh E; Asada H; Morioka H; Kishida T; Nakao M; Mizutani Y; Kawauchi A; Kita M; Imanishi J; Miki T Gene Ther; 2003 Mar; 10(5):434-42. PubMed ID: 12601398 [TBL] [Abstract][Full Text] [Related]
35. Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand. Matsuno H; Yudoh K; Watanabe Y; Nakazawa F; Aono H; Kimura T J Rheumatol; 2001 Jan; 28(1):22-8. PubMed ID: 11196534 [TBL] [Abstract][Full Text] [Related]
36. Central role of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial fibroblasts. Itoh K; Hase H; Kojima H; Saotome K; Nishioka K; Kobata T Rheumatology (Oxford); 2004 Mar; 43(3):277-85. PubMed ID: 14623946 [TBL] [Abstract][Full Text] [Related]
37. Apomodulation as a novel therapeutic concept for the regulation of apoptosis in rheumatoid synoviocytes. Kobayashi T; Okamoto K; Kobata T; Hasumuna T; Nishioka K Curr Opin Rheumatol; 1999 May; 11(3):188-93. PubMed ID: 10328578 [TBL] [Abstract][Full Text] [Related]
38. Involvement of Fas (CD95/APO-1) and Fas ligand in apoptosis induced by ganciclovir treatment of tumor cells transduced with herpes simplex virus thymidine kinase. Wei SJ; Chao Y; Shih YL; Yang DM; Hung YM; Yang WK Gene Ther; 1999 Mar; 6(3):420-31. PubMed ID: 10435092 [TBL] [Abstract][Full Text] [Related]
39. FasL gene therapy: a new therapeutic modality for head and neck cancer. ElOjeimy S; McKillop JC; El-Zawahry AM; Holman DH; Liu X; Schwartz DA; Day TA; Dong JY; Norris JS Cancer Gene Ther; 2006 Aug; 13(8):739-45. PubMed ID: 16543918 [TBL] [Abstract][Full Text] [Related]
40. C-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid synoviocytes. Hashiramoto A; Sano H; Maekawa T; Kawahito Y; Kimura S; Kusaka Y; Wilder RL; Kato H; Kondo M; Nakajima H Arthritis Rheum; 1999 May; 42(5):954-62. PubMed ID: 10323451 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]